Trial Outcomes & Findings for Clinical Accuracy of the welloStationX (NCT NCT03758157)

NCT ID: NCT03758157

Last Updated: 2021-07-07

Results Overview

Agreement through clinical bias evaluation was calculated as the Mean Bias ± Standard Deviation (SD) by subtracting the first output measurement recorded with the welloStationX thermometer (DUT) from the corresponding output measurement recorded with the Welch Allyn SureTemp oral thermometer for each subject, and then calculating the Mean Bias ± SD of the biases.

Recruitment status

COMPLETED

Target enrollment

110 participants

Primary outcome timeframe

one day

Results posted on

2021-07-07

Participant Flow

Participant milestones

Participant milestones
Measure
welloStationX Automated Non-Contact Thermometer
welloStationX: welloStationX is an automated electronic thermometer using an infrared sensor of the surface of the forehead to measure human body skin temperature to screen for fever.
Overall Study
STARTED
110
Overall Study
COMPLETED
110
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Clinical Accuracy of the welloStationX

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Temperature Measurement
n=110 Participants
welloStationX: welloStationX is an automated electronic thermometer using an infrared sensor of the surface of the forehead to measure human body skin temperature to screen for fever. SureTemp: SureTemp is an oral thermometer to measure human body skin temperature.
Age, Continuous
44.78 years
STANDARD_DEVIATION 16.14 • n=99 Participants
Sex: Female, Male
Female
74 Participants
n=99 Participants
Sex: Female, Male
Male
36 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
54 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
56 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
Region of Enrollment
United States
110 Participants
n=99 Participants
febrility
febrile subjects (temperature >=99.5 deg. C)
33 Participants
n=99 Participants
febrility
afebrile subjects (temperature < 99.5 deg. C)
77 Participants
n=99 Participants

PRIMARY outcome

Timeframe: one day

Agreement through clinical bias evaluation was calculated as the Mean Bias ± Standard Deviation (SD) by subtracting the first output measurement recorded with the welloStationX thermometer (DUT) from the corresponding output measurement recorded with the Welch Allyn SureTemp oral thermometer for each subject, and then calculating the Mean Bias ± SD of the biases.

Outcome measures

Outcome measures
Measure
Temperature Measurement
n=110 Participants
Each subject will have his or her temperature measured by both the welloStationX Automated Non-Contact Thermometer and the Welch Allyn SureTemp Oral Thermometer.
Clinical Agreement Through Clinical Bias Evaluation
0.04 degrees Farehheit
Standard Deviation 0.42

SECONDARY outcome

Timeframe: one day

Clinical Repeatability was calculated using the pooled standard deviations of the triplicate measurements recorded by the welloStationX.

Outcome measures

Outcome measures
Measure
Temperature Measurement
n=110 Participants
Each subject will have his or her temperature measured by both the welloStationX Automated Non-Contact Thermometer and the Welch Allyn SureTemp Oral Thermometer.
Clinical Repeatability
0.062 degrees Farehheit

Adverse Events

Temperature Measurement

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Alan C. Heller

Wello, Inc.

Phone: 469-522-5200

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place